NCT04660370View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 9, 2021

Primary Completion Date

February 24, 2021

Study Completion Date

April 15, 2021

Conditions
Hypertension and Dyslipidemia
Interventions
DRUG

CKD-348

QD, PO

DRUG

CKD-828, D097, D337

QD, PO

Trial Locations (1)

08779

H Plus Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY